Why the study?
Does MR imaging accurately define the presence, distribution, and severity of hypertrophy in patients with hypertrophic cardiomyopathy compared to healthy volunteers?
Does MR imaging accurately define the presence, distribution, and severity of hypertrophy in patients with hypertrophic cardiomyopathy compared to healthy volunteers?
MR imaging is capable of defining the morphological characteristics and severity of different subtypes of hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
MR imaging supports morphological assessment of HCM subtypes; leaves open its diagnostic superiority over echocardiography in routine practice.
Park et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: